Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression
Open accessThe DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) comprises fat-accumulating conditions within hepatocytes that can cause severe liver damage and metabolic comorbidities. Studies suggest that mitochondrial dysfunction contributes to its development and progression and that the hepatic lipidome changes extensively in obesity and in NAFLD. To gain insight into the relationship between lipid metabolism and disease progression through different stages of NAFLD, we performed lipidomic analysis of plasma and liver biopsy samples from obese patients with nonalcoholic fatty liver (NAFL) or nonalcoholic steatohepatitis (NASH) and from those without NAFLD. Congruent with earlier studies, hepatic lipid levels overall increased with NAFLD. Lipid species that differed with NAFLD severity were related to mitochondrial dysfunction; specifically, hepatic cardiolipin and ubiquinone accumulated in NAFL, and levels of acylcarnitine increased with NASH. We propose that increased levels of cardiolipin and ubiquinone may help to preserve mitochondrial function in early NAFLD, but that mitochondrial function eventually fails with progression to NASH, leading to increased acylcarnitine. We also found a negative association between hepatic odd-chain phosphatidylcholine and NAFLD, which may result from mitochondrial dysfunction-related impairment of branched-chain amino acid catabolism. Overall, these data suggest a close link between accumulation of specific hepatic lipid species, mitochondrial dysfunction, and the progression of NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ceramides are among the most studied lipids because of their lipotoxic activity in several organs and have been reported to be increased in the plasma of patients with MASLD.94,[99], [100], [101], [102],[107], [108], [109],115”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [99]
In the citing paper
“Peng et al.99 showed that TAGs, DAGs, ceramides, PE, lysophosphatidylethanolamine and cholesterol esters were significantly increased, and PC and LPC significantly reduced, in MASH vs. controls (Table 1).”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [99]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Branched-chain amino acids in metabolic signalling and insulin resistance
Lynch, C. J., & Adams, S. H. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.171 · Cited by 1,461
A lipidomic analysis of nonalcoholic fatty liver disease
Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338 · cited 1×
“In the current study, we found increased hepatic levels of TG, DG, CE, and free cholesterol in individuals with NAFLD, which is in congruence with earlier studies (19, 20).”
ResultKoliaki, C., Szendroedi, J., Kaul, K., Jelenik, T., Nowotny, P., Jankowiak, F., Herder, C., Carstensen, M., Krausch, M., Knoefel, W. T., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.004 · Cited by 1,032
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
Rolo, A. P., Teodoro, J. S., & Palmeira, C. M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.003 · Cited by 955
Cardiolipin Stabilizes Respiratory Chain Supercomplexes
Pfeiffer, K., Gohil, V., Stuart, R. A., Hunte, C., Brandt, U., Greenberg, M. L., & Schägger, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308366200 · Cited by 843 · cited 1×
“Cardiolipin is also important for mitochondrial biogenesis and the assembly of respiratory enzyme supercomplexes (25).”
BackgroundMitochondrial dysfunction in Nash: causes, consequences and possible means to prevent it
Begriche, K., Igoudjil, A., Pessayre, D., & Fromenty, B. (2006) · Mitochondrion · doi:10.1016/j.mito.2005.10.004 · Cited by 753 · cited 1×
“Mitochondrial dysfunction has been suggested to play a pivotal role in the pathogenesis of NAFLD (13, 14).”
BackgroundDefective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis.
Pérez-Carreras, M., Del Hoyo, P., Martín, M. A., Rubio, J. C., Martín, A., Castellano, G., Colina, F., Arenas, J., & Solis-Herruzo, J. A. (2003) · Hepatology · doi:10.1002/hep.1840380426 · Cited by 734
ARAYA, J., RODRIGO, R., VIDELA, L. A., THIELEMANN, L., ORELLANA, M., PETTINELLI, P., & PONIACHIK, J. (2004) · Clinical Science · doi:10.1042/cs20030326 · Cited by 700
Cited by
Items 101–200 of 234
Xiong, Y., Wen, S., Li, Y., Wei, Y., Fang, B., Li, C., Huang, Q., & Lin, X. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174770 · Cited by 18
The central role of mitochondrial metabolism in hepatic steatosis
Win, S., Than, T. A., Kaplowitz, N., Wong, N., Arya, A., Win, Z. T., Win, S. H., Phyu, E., Kuemerle, C., Suh, J., et al. (2024) · Exploration of Digestive Diseases · doi:10.37349/edd.2024.00039 · Cited by 19
Impact of metabolic stress induced by diets, aging and fasting on tissue oxygen consumption
Mackert, O., Wirth, E. K., Sun, R., Winkler, J. L., Liu, A., Renko, K., Kunz, S., Spranger, J., & Brachs, S. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101563 · Cited by 19
Glucose-induced enhanced anti-oxidant activity inhibits apoptosis in goose fatty liver
Sun, Q., Dai, E., Chen, M., Zhang, J., Mu, J., Liu, L., Geng, T., Gong, D., Zhang, Y., & Zhao, M. (2023) · Journal of Animal Science · doi:10.1093/jas/skad059 · Cited by 17
Zhao, Q., 杭州310053,中国, 杭., Ge, L., Zhang, K., Chen, H.-F., Zhan, X.-X., Yang, Y. J., Dang, Q.-L., Zheng, Y., Zhou, H., et al. (2020) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2020.051 · Cited by 18
“(Krishnan et al, 2018) and (Peng et al, 2018) performed transcriptomic and lipidomic analysis of liver samples from humans and mice with MAFLD and identified mitochondrial dysfunction as the driving force for the progression of MAFLD.”
Shu, Y., Hassan, F., Coppola, V., Baskin, K. K., Han, X., Mehta, N. K., Ostrowski, M. C., & Mehta, K. D. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101133 · Cited by 18
Savva, C., Helguero, L. A., Gonzalez-Granillo, M. A., Couto, D., Melo, T., Li, X., Angelin, B., Domingues, M. R., Kutter, C., & Korach-André, M. (2021) · Communications Biology · doi:10.1038/s42003-020-01513-z · Cited by 17
He, D., Su, Y., Meng, D., Wang, X., Wang, J., & Ye, H. (2021) · Journal of Mass Spectrometry and Advances in the Clinical Lab · doi:10.1016/j.jmsacl.2021.10.001 · Cited by 17
Frandsen, H. S., Vej-Nielsen, J. M., Smith, L. E., Sun, L., Mikkelsen, K. L., Thulesen, A. P., Hagensen, C. E., Yang, F., & Rogowska-Wrzesińska, A. (2022) · Cells · doi:10.3390/cells11203216 · Cited by 18
“95%) indirectly relates to NAFLD since a decrease in PG has been previously related to mitochondrial dysfunction [51].”
BackgroundResultFan, C., Wang, G., Miao, C. H. E. N., Li, Y., Tang, X., & Dai, Y. (2023) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(23)60403-0 · Cited by 19
Impact of mitochondrial lipid alterations on liver disease mechanisms and progression
Fàbrega, L., Fernández-Checa, J. C., de la Rosa, L. C., & García‐Ruiz, C. (2024) · Exploration of Digestive Diseases · doi:10.37349/edd.2024.00057 · Cited by 21
Gaskell, H., Ge, X., Désert, R., Das, S., Han, H., Lantvit, D. D., Guzman, G., & Nieto, N. (2019) · Hepatology Communications · doi:10.1002/hep4.1448 · Cited by 16
Applying Lipidomics to Non-Alcoholic Fatty Liver Disease: A Clinical Perspective
Huang, J., Sigon, G., Mullish, B. H., Wang, D., Sharma, R., Manousou, P., & Forlano, R. (2023) · Nutrients · doi:10.3390/nu15081992 · Cited by 16
Liu, J., Wu, H., Zhang, Y., Hu, C., Zhen, D., Fu, P., & He, Y. (2023) · Nutrients · doi:10.3390/nu15214573 · Cited by 15
“These neutral lipids, extensively implicated in prior research, have exhibited pronounced elevation in the liver biopsy of NAFLD patients [23,24].”
BackgroundZhang, L., Du, Y., Li, Y., Wang, T., Pan, Y., Xue, X., Mu, X., Qiu, J., & Qian, Y. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.136958 · Cited by 16
Association between Serum Selenium Levels and Lipids among People with and without Diabetes
Nie, Q., Wang, C., & Zhou, L. (2023) · Nutrients · doi:10.3390/nu15143190 · Cited by 14
Balkrishna, A., Gohel, V., Kumari, P., Manik, M., Bhattacharya, K., Dev, R., & Varshney, A. (2022) · Bioengineered · doi:10.1080/21655979.2022.2065789 · Cited by 15
Targeted Mitochondrial Delivery to Hepatocytes: A Review
Heineman, B. D., Liu, X., & Wu, G. Y. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00093 · Cited by 14
Arruda, V. M., Azevedo, G. T., Granato, M. J. M. G., Matos, A. C. P., Araújo, T. G., & Guerra, J. F. D. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179591 · Cited by 13
“Lipidomic profiling studies have shown that plasma FFA concentrations are around 1 mM in patients with NAFLD [22,23].”
BackgroundThe Polymethoxyflavone Sudachitin Modulates the Circadian Clock and Improves Liver Physiology
Mawatari, K., Koike, N., Nohara, K., Wirianto, M., Uebanso, T., Shimohata, T., Shikishima, Y., Miura, H., Yoshitaka, N. I. I., Burish, M. J., et al. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200270 · Cited by 13
The Cumulative Risk Assessment of Hepatotoxic Chemicals: A Hepatic Histopathology Perspective
Foster, J. R., Beninel, G. S., & Melching‐Kollmuss, S. (2020) · Toxicologic Pathology · doi:10.1177/0192623319895481 · Cited by 13
Song, W., Wang, T., Cui, X., Li, L., Chen, B. Y., Li, Y., & Yue, T. (2023) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.12774 · Cited by 13
Peng, K., Barlow, C. K., Kammoun, H. L., Mellett, N. A., Weir, J. M., Murphy, A. J., Febbraio, M. A., & Meikle, P. J. (2021) · Metabolites · doi:10.3390/metabo11030188 · Cited by 12
“Liquid chromatography tandem mass spectrometry (LC-MS/MS) was used for targeted lipidomic analysis, similar to our earlier studies [41,42].”
ResultSelf-citationCommon Pathogenetic Pathways of Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
Giannopoulos, C., Tzima, I. G., Tentolouris, N., & Vasileiadis, I. (2023) · Current Diabetes Reviews · doi:10.2174/1573399819666230216112032 · Cited by 14
Mahler, C. A., Snoke, D. B., Cole, R. M., Angelotti, A., Sparagna, G. C., Baskin, K. K., Ni, A., & Belury, M. A. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.12.037 · Cited by 13
Li, S., Liu, A.-B., Yu, Y., & Ma, J.-H. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1407738 · Cited by 16
Florentino, R. M., Animasahun, O. H., Haep, N., Nenwani, M., Omoloja, K., Altay, L. N., Achreja, A., Morita, K., Motomura, T., Díaz‐Aragon, R., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.193805 · Cited by 14
The presence of odd-chain fatty acids inDrosophilaphospholipids
Sato, A., Ohhara, Y., Miura, S., & Yamakawa‐Kobayashi, K. (2020) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2020.1790337 · Cited by 12
The inhibition of microtubule dynamics instability alters lipid homeostasis in TM4 Sertoli cells
Vallés, A. S., Tenconi, P. E., Luquez, J. M., & Furland, N. E. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115607 · Cited by 11
Guo, B., Zhou, Y., Liu, B., He, Y., Chen, F., & Cheng, K. (2021) · Pharmaceuticals · doi:10.3390/ph14101004 · Cited by 12
“Usually, NAFLD easily causes mitochondrial dysfunction, which may include de‐ creased mitochondrial membrane potential (MMP) and down‐regulated oxidative phos‐ phorylation [9].”
BackgroundAlterations of Lipid Profile in Livers with Impaired Lipophagy
Jonas, W., Schwerbel, K., Zellner, L., Jähnert, M., Gottmann, P., & Schürmann, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911863 · Cited by 11
“This resulted in a significant increase of the n-6 to n-3 ratio and a decrease of the n-3 index (Figure 3C, upper panel), which have already been observed in NASH patients and are both markers of inflammatory processes during disease progression [18].”
BackgroundEvaluating the safety and efficiency of nanomaterials: A focus on mitochondrial health
Siquan, L., Weilin, C., Chen, X., Meiyan, Z., Weihong, G., & Xiaoli, F. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117484 · Cited by 13
Wang, D., Zhang, M., Zhang, Y., Yin, Z., Zhang, S., Zhao, Z., & Duan, Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140444 · Cited by 10
Ma, L., Liu, H., Ge, Z., Bai, B., Zhao, J., Chen, S., Zhou, B., Zhang, J., Wang, T., & Wang, C. (2025) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2025.104204 · Cited by 10
Mechanosensing by Piezo1 in gastric ghrelin cells contributes to hepatic lipid homeostasis in mice
Zhang, J., Zhao, Y., Wu, S., Han, M., Gao, L., Yang, K., Chen, H., Wang, C., & Xu, G. (2024) · Science Signaling · doi:10.1126/scisignal.adq9463 · Cited by 10
“Conversely, in individuals with MASLD, lipid oxidation processes are often impaired, ham-pering the breakdown and utilization of fatty acids and further exacer-bating hepatic fat accumulation ( 25 ).”
BackgroundLiu, J., Song, R., Su, S., Qi, N., Li, Q., Xie, Z., & Yu, S. (2022) · Animals · doi:10.3390/ani12121530 · Cited by 11
“In humans, betaine prevents alcohol-induced steatosis by reducing liver fat deposition [32]; meanwhile, increased NAFLD severity is associated with betaine insufficiency, and elevated betaine levels improve liver injury and reduce fat deposition [33].”
BackgroundRad, M. G., Sharifi, M., Meamar, R., & Soltani, N. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117053 · Cited by 10
Cheng, Z., & Montgomery, M. K. (2025) · Clinical Science · doi:10.1042/cs20257631 · Cited by 10
“While a recent study suggested reduced hepatic PI in patients with MASLD [485], several other studies observed no changes in hepatic PI content [486–489].”
Spontaneous liver disease in wild-type C57BL/6JOlaHsd mice fed semisynthetic diet
Ronda, O. A. H. O., van de Heijning, B. J. M., de Bruin, A., Thomas, R., Martini, I. A., Koehorst, M., Gerding, A., Koster, M. H., Bloks, V. W., Jurdzinski, A., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232069 · Cited by 9
Chowdhury, R. R., Grosso, M., Gadara, D. C., Spáčil, Z., Vidová, V., Sovadinová, I., & Babica, P. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.111046 · Cited by 9
El-Derany, M. O., & AbdelHamid, S. G. (2022) · Life · doi:10.3390/life12030355 · Cited by 11
Longo, M., Meroni, M., Erconi, V., Carli, F., Macchi, C., Fortunato, F., Ronchi, D., Sabatini, S., Paolini, E., Caro, E. R. D., et al. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.12.070 · Cited by 10
Yalcin, E. B., Tong, M., Cao, K., Huang, C., & de la Monte, S. M. (2023) · European Journal of Biology and Biotechnology · doi:10.24018/ejbio.2023.4.1.135 · Cited by 10
Gunn, P. J., Pramfalk, C., Millar, V., Cornfield, T., Hutchinson, M., Johnson, E. M., Nagarajan, S. R., Troncoso‐Rey, P., Mithen, R. F., Pinnick, K. E., et al. (2020) · Physiological Reports · doi:10.14814/phy2.14482 · Cited by 12
“It has been hypothesized that in the early stages of steatosis there is an increase in mitochondrial activity to dispose of excess FA, before microsomal oxidation and ROS increase and mitochondrial activity decreases (Koliaki et al., 2015; Peng et al., 2018).”
BackgroundMolecular targets regulating endoplasmic reticulum-mitochondria crosstalk for NAFLD treatment
Zhang, C., & Yang, M. J. (2021) · Exploration of Medicine · doi:10.37349/emed.2021.00066 · Cited by 8
Yang, N., Zhang, J., Guo, J., Xiang, Q., Huang, Y., Wen, J., Liu, Q., Hu, T., Chen, Y., & Rao, C. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117086 · Cited by 10
The Role Played by Mitochondria in Polycystic Ovary Syndrome
Sun, C., Zhao, S., Pan, Z., Li, J., Wang, Y., & Kuang, H. (2024) · DNA and Cell Biology · doi:10.1089/dna.2023.0345 · Cited by 8
“…damage may be aggravated by inducing lipid toxicity, and the vicious cycle formed by these leads to the liver cell inflammation, death, fibrosis, and other pathological changes, while facilitating the development of liver steatosis into nonalcoholic steatohepatitis (NASH) (Peng et al., 2018).”
InfluentialYang, L., Wang, F., Liu, S., Xian, Z., Yang, S., Xu, Y., Shu, L., Yan, X., He, J., Li, X., et al. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.103068 · Cited by 8
PET imaging of glucose and fatty acid metabolism for NAFLD patients
Gullberg, G. T., Shrestha, U. M., & Seo, Y. (2018) · Journal of Nuclear Cardiology · doi:10.1007/s12350-018-01532-8 · Cited by 7
Immunology and treatments of fatty liver disease
Tang, S., Wu, S., Zhang, W., Ma, L., Zuo, L., & Wang, H. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03920-1 · Cited by 6
“However, the imbalance of this adaptive mechanism can lead to decreased activity of the mitochondrial respiratory chain complexes and increased production of oxidative stress, which is thought to be an important factor in the development of NAFLD (Durand et al. 2021; Peng et al. 2018).”
Abnormal ac4C modification in metabolic dysfunction associated steatotic liver cells
Zhang, X., Zheng, Y., Yang, J., Yang, Y., He, Q., Xu, M., Long, F., & Yang, Y. (2025) · Scientific Reports · doi:10.1038/s41598-024-84564-0 · Cited by 6
“Research has confirmed that mitochondrial dysfunction and dynamics are closely related to neurodegenerative and metabolic diseases, including MASLD 31 .”
Katti, P., Prasad, P., Masenga, S. K., Venkhatesh, P., Vue, Z., Marshall, A. G., Rodriguez, B., Le, H., Lopez, E. G., Murphy, A. C., et al. (2026) · Aging Cell · doi:10.1111/acel.70534 · Cited by 8
“Hex2Cer contributes to mitochondrial membrane composition (Peng et al. 2018; Schenkel and Bakovic 2014) and may influence membrane curvature and organelle dynamics.”
Zhao, J., Xu, X., Wei, X., Zhang, S., Xu, H., Wei, X., Zhang, Y., & Zhang, J. (2023) · Biomedicines · doi:10.3390/biomedicines11092416 · Cited by 6
“In addition, several studies have found that mitochondrial dysfunction can disrupt hepatic lipid homeostasis, which contributes to the pathogenesis of NAFLD [41–43].”
Li, S., Zhi, Y., Mu, W., Li, M., & Li, M. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176300 · Cited by 7
Yu, Z., Wang, S., Hou, H., Ma, L., & Zhu, Y. (2020) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201900451 · Cited by 7
Li, Q., Lin, Y., Xu, J., Liu, Y., Jing, Y., Huang, R., Song, C., Zhang, L., & Jin, S. (2023) · Molecules · doi:10.3390/molecules28114522 · Cited by 6
“Because the disruption of lipid metabolism could result in statistically significant changes in mitochondrial CL content, CL may be a critical regulator of mitochondrial health in such diseases [20,21].”
BackgroundWang, X., Hu, Y., Zhu, W., & Wang, D. (2023) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-023-05091-x · Cited by 5
“Moreover, acylcarnitines, together with cardiolipin and ubiquinone, are lipid classes associated with mitochondrial function [36].”
Jiang, Z., Hayashi, T., Kashima, K., Kurotani, K., Shirouchi, B., Mizoue, T., & Sato, M. (2020) · Lipids · doi:10.1002/lipd.12251 · Cited by 7
Zhou, L., Liang, X., Xie, M., Yin, J., Huang, Y., Li, X., Shan, Z., Chen, L., Zhang, Y., Luo, C., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.789577 · Cited by 5
“Mitochondrial dysfunction could disturb lipid metabolism through several mechanisms, including leading to endoplasmic reticulum stress, impairing autophagy, and then increasing lipogenesis (29, 30).”
BackgroundMolina‐Molina, E., Shanmugam, H., Palo, D. D., Grattagliano, I., & Portincasa, P. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1433-4_11 · Cited by 7
Grzych, G., Bernard, L., Lestrelin, R., Tailleux, A., & Staels, B. (2022) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2022.09.005 · Cited by 6
Xiao, L., Chen, B., Chen, C., Xiao, F., Li, M., Zhuang, M., Dai, Y., & Wu, K. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131156 · Cited by 4
Yang, Y., Jiao, L., Huang, Y., Shang, H., Li, E., Chang, H., Cui, H., & Wan, Y. (2025) · Environmental Health Perspectives · doi:10.1289/ehp15435 · Cited by 4
Li, J., Wu, J., Chen, Q., Yu, H., Liu, M., Wang, Y., Zhang, Y., & Wang, T. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116878 · Cited by 4
Copine7 deficiency leads to hepatic fat accumulation via mitochondrial dysfunction
Hwang, G., Seo, H.-J., & Park, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21676 · Cited by 5
“To identify how Cpne7 deficiency induced lipid accumulation, we analyzed mitochondrial function, which is known to be strongly associated with lipid metabolism [10,23 – 25].”
BackgroundMei, Y., Sun, X., Huang, S., Wu, X., Ho, K.-T., Lu, L., Chen, C., Li, J., Liu, J., & Li, G. (2024) · Polish Journal of Food and Nutrition Sciences · doi:10.31883/pjfns/182927 · Cited by 4
Tan, N. Y. T., Shumbayawonda, E., Cheng, L. T., Low, A. S. C., Lim, C. H., Eng, A. K. H., Chan, W. H., Lee, P. C., Tay, M. F., Chang, J. P.-E., et al. (2024) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.039.02.20 · Cited by 4
“19 24-26 Though not demonstrated in this study, levels of unsaturated long-chain acylcarnitine species such as C14:1 and C18:1 were found to be increased with the progression of fibrosis.”
BackgroundCardiolipin deficiency disrupts electron transport chain and drives steatohepatitis
Brothwell, M. J., Cao, G., Maschek, J. A., Poss, A. M., Peterlin, A. D., Wang, L., Baker, T. B., Shahtout, J. L., Siripoksup, P., Pearce, Q., et al. (2025) · eLife · doi:10.7554/elife.106976 · Cited by 6
“This finding is consistent with previous studies demonstrating that MASLD is associated with reduced CL levels, and that tetralinoleoyl-CL is preferentially reduced in MASLD ( Peng et al., 2018 ; Paradies et al., 2014 ; Durand et al., 2021 ; Shin et al., 2023 ).”
Exploration of Digestive Diseases
(2022) · Exploration of Digestive Diseases · doi:10.37349/edd · Cited by 4
Makri, E. S., Mouskeftara, T., Gika, H., Xanthopoulos, K., Makri, E., Mavrommatis-Parasidis, P., Tsingotjidou, A., Cheva, A., Goulas, A., & Pοlyzos, S. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199273 · Cited by 3
“As for the use of NITs, another study which compared patients with MASLD and obesity with healthy controls, supported that the majority of the highly correlated lipid species between plasma and liver belonged to phospholipid classes, including PC, LPC, PE, PI and SM [58].”
Fu, J., Lan, Y., Liang, Y., Yang, X., Tang, R., Wang, Y., Luo, Y., & Liu, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010407 · Cited by 3
MTARC1 Inactivation Remodels Lipid Droplets to Protect Against Metabolic Fatty Liver Disease
Tie, M., Hu, L., Yang, Y., Song, S., Zhu, Q., Li, J., Wang, W., Xu, P., Yu, J., Wu, M., et al. (2026) · Liver International · doi:10.1111/liv.70539 · Cited by 3
Zhang, X. D., Ma, G., Wang, B., Liu, R., & Guo, Y. (2026) · Poultry Science · doi:10.1016/j.psj.2026.106655 · Cited by 3
“Lipid deposition is influenced by lipid synthesis, oxidation, and transport (Smink et al., 2010), which are closely related to mitochondrial function (Peng et al., 2018; Li et al., 2024).”
The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes
Taylor, G., Smith, K., Scragg, J., McDonald, T. J., Shaw, J., West, D. J., & Roberts, L. D. (2024) · Diabetologia · doi:10.1007/s00125-024-06153-0 · Cited by 4
Semertzidis, A., Mouskeftara, T., Gika, H., Pousinis, P., Makedou, K., Goulas, A., Kountouras, J., & Pοlyzos, S. A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133798 · Cited by 3
“Peng et al. reported higher total hepatic CE content in patients with NAFL and NASH, along with an increase in the percentage of docosahexaenoic acid (DHA, FA 22:6) within CE in NASH compared with the controls [37].”
ResultDietary Rhythms and MASLD-Related Hepatocellular Carcinoma
Malakmahmoudi, N., Pisu, R., Laconi, E., & Marongiu, F. (2024) · Cancers · doi:10.3390/cancers16203481 · Cited by 3
Deng, Y., Cui, J., Jiang, Y., Zhang, J., Jiang, J., Zhang, Q., & Hu, Y. (2025) · Foods · doi:10.3390/foods14071257 · Cited by 3
“Lipidomics is a valuable tool that aids in the identification of biomarkers and metabolic pathways associated with diseases [12,53–55].”
Walker, O. S., May, L. L., & Raha, S. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3495-0_12 · Cited by 2
Lin, F., & Chen, Z. (2025) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2025.127596 · Cited by 2
Lu, C.-H., Hsieh, Y.-R., Huang, S.-Y., Wang, W., Chang, C.-W., Panunggal, B., Chang, I., Chen, C.-L., Chang, C.-C., & Kao, W. (2025) · Obesity Surgery · doi:10.1007/s11695-025-08450-y · Cited by 2
“Although limited research has reported changes in the levels of CL in patients with NAFLD, elevated levels have been observed in the liver [30].”
The effect of seminal plasma on the mass motility of epididymal ram spermatozoa
de Hoek, M. V., Rickard, J. P., & GRAAF, S. P. D. (2026) · Reproduction Fertility and Development · doi:10.1071/rd25174 · Cited by 2
The Impact of Traditional Chinese Medicine on Mitophagy in Disease Models
Yu, L., Shi, T., Li, Y.-Q., Mu, J.-K., Yang, Y.-Q., Li, W., Yu, J., & Yang, X. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612827666211006150410 · Cited by 2
Khoshkerdar, A., Eid, N., Batra, V., Baker, N., Holmes, N., Henson, S., Sang, F., Wright, V. J., McLaren, J., Shakesheff, K. M., et al. (2024) · Nutrients · doi:10.3390/nu16121879 · Cited by 2
“Impairments in β -oxidation have been linked to the accumulation of hepatic lipid-species, mitochondrial dysfunction and the development of metabolic diseases such as non-alcoholic fatty liver disease [45].”
BackgroundHamed, G. M., Abou-Bakr, D. A., Saleh, N., Elshishiny, M. I., & Morsy, W. E. (2024) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093024040124 · Cited by 2
Leopold, M., Sanchez, P. B. M., Krizanac, M., Štancl, P., Karlić, R., Prabutzki, P., Parafianczuk, V., Schiller, J., Asimakopoulos, A., Engel, K. M., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2024.159574 · Cited by 2
Sehgal, R., Jähnert, M., Lazaratos, M., Speckmann, T., Schumacher, F., Kleuser, B., Ouni, M., Jonas, W., & Schürmann, A. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100767 · Cited by 3
“However, in various human studies, the liver TAG increased with the severity of liver damage and correlated strongly with homeostatic model assessment for insulin resistance (36 – 38).”
Common pathogenetic mechanisms of non-alcoholic fatty liver disease and polycystic ovary syndrome
Ilovayskaya, I. (2024) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-230-10-90-97 · Cited by 2
Liu, T. C., Xue, Y., Wang, L., Zhao, N., Zhao, T., Xie, K., Wan, F., Tan, Z., & Tang, M. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115864 · Cited by 3
In Utero Protein Deficiency Leads to Impaired Hepatic Lipid Metabolism in Adult Male Rats
Vidyadharan, V. A., Yallampalli, C., & Blesson, C. S. (2026) · Journal of Nutrition · doi:10.1016/j.tjnut.2026.101405 · Cited by 1
Li, Y., Han, D., Liu, J., Qiao, Y., Jiaoxia, W. E. I., Lu, H., & Yao, L. (2026) · Chinese Medicine · doi:10.1186/s13020-026-01362-8 · Cited by 1
“In addition, acyl-carnitine accumulation is sufficient to mediate mitochondrial damage and stimulate ROS overproduction [42, 43].”
Anspach, G., Flight, R. M., Park, S., He, D., Wang, C., Moseley, H., & Helsley, R. N. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101081 · Cited by 2
“Linoleic acid is the most abundant FA in the cardiolipin pool (62) and LA-enrichment into cardiolipin and other phospholipids (such as PE) associate with mitochondria uncoupling, oxygen consumption rate, and improve mitochondrial respiration (63).”
InfluentialBioactive lipids in metabolic liver disease
Morales-Olvera, C. G., Sánchez-Pérez, C. A., Barbero-Becerra, V. J., Juárez-Hernández, E., Uribe, M., & Chávez-Tapia, N. C. (2021) · Studies in natural products chemistry · doi:10.1016/b978-0-12-819487-4.00005-7 · Cited by 1
Sudden death of a 2-year-old child due to alpha-ketoadipic aciduria
Kondou, H., Ichioka, H., Akasaka, Y., Kondo, H., & Ikegaya, H. (2022) · Forensic Science Medicine and Pathology · doi:10.1007/s12024-022-00483-4 · Cited by 1
“Furthermore, the fact that mitochondrial dysfunction could cause fatty liver is already known [5, 6].”
BackgroundUnravelling the molecular mechanisms underlying mitochondrial dysfunction in metabolic diseases
Mposhi, A. (2020) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.146092791 · Cited by 2
Non-alcoholic liver disease and gut bacteria
Ponzetto, A., Figura, N., & Riva, P. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.02.012
Chen, H., Zhang, Y., Huang, J., Yang, F., Zhang, Y., Guo, T., Mao, Y., Liu, C., Cheng, L., Li, Y., et al. (2021) · Austin Journal of Pathology & Laboratory Medicine · doi:10.26420/austinjpathollabmed.2021.1033
“And several studies have demonstrated that mitochondrial dysfunction played a significant role in NAFLD [29,30] and ALD [31,32].”
BackgroundKakimoto, P. A. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2021.tde-10082023-115406
de Souza, J. G. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.6.2023.tde-30102023-162135 · Cited by 1
Siddique, R., Mehmood, M. H., & Shehzad, M. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18807-7.00018-1
Metadata
- Authors
- Peng, K.-Y., Watt, M. J., Rensen, S., Greve, J. W., Huynh, K., Jayawardana, K. S., Meikle, P. J., & Meex, R. C. R.
- Affiliations
- Baker Heart and Diabetes Institute (AU)
- The University of Melbourne (AU)
- Maastricht University Medical Centre (NL)
- Zuyderland Medisch Centrum (NL)
- Corresponding author
- Meikle, Peter J.
- Meex, Ruth C.R.
- ORCID
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 59
- Issue
- 10
- Pages
- 1977-1986
- ISSN
- 0022-2275 (ISSN-L)
- PMC
- PMC6168306
- OpenAlex
- W2884907724
- Cited by
- 220
- References
- 57
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 33 · 2023: 39 · 2022: 25 · 2021: 43 · 2020: 27 · 2019: 13 · 2018: 2
- FWCI
- 16.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 708 d)
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- National Health and Medical Research Council (APP1061278, APP1077703, APP1042095)
- University of Melbourne
- H2020 Marie Skłodowska-Curie Actions (H2020-MSCA-IF)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Keywords
- non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, mitochondrial dysfunction, hepatic lipidome, cardiolipin, coenzyme Q10, acylcarnitines, branched-chain amino acid catabolism, disease progression, obesity, plasma lipidomics, liver biopsy
- MeSH terms
- Adult, Female, Humans, Liver, Male, Middle Aged, Mitochondria, Cohort Studies, Disease Progression, Lipid Metabolism, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.